Funding

Sources of Funding, Updated January 2019

ICER’s mission is funded through a diverse combination of sources as grants, contracts and unrestricted gifts; funding is not accepted from manufacturers or private insurers to perform reviews of specific treatments or therapies. ICER’s regional councils, CTAF, Midwest CEPAC and New England CEPAC are also funded by private foundations.  In 2019, ICER received funding from the following sources:

  • Arthur J. Gallagher & Co.
  • Bank of America
  • BioPoint Inc.
  • Blue Cross Blue Shield of Massachusetts
  • California Health Care Foundation
  • Commonwealth Fund
  • Eastern Medicaid Pharmacy Administrators Association
  • Evercore Partners Services East LLC
  • Harvard Medical School
  • Harvard Pilgrim Health Care
  • ISPOR Colombia Chapter
  • Kaiser Foundation Health Plan Inc.
  • Arnold Ventures
  • Magellan Health
  • Mass Mutual Life Insurance Company
  • MorningStar
  • National Governors Association
  • National Health Council
  • National Institute for Health Care Management Research and Educational Foundation
  • National Institute of Health/University of Massachusetts Medical School
  • NESCSO/University of Massachusetts
  • Partners Healthcare
  • Western Medicaid Pharmacy Administrators Association

ICER also receives support from pharmaceutical and health insurance companies for the annual ICER Policy Summit, Evidence Dialogue webinars, and other membership activities.  Current members include:

  • Allergan
  • Alnylam Pharmaceuticals
  • America’s Health Insurance Plans (AHIP)
  • Anthem
  • AstraZeneca
  • Biogen
  • Blue Shield of California
  • Boehringer-Ingelheim
  • Cambia Health Solutions and MedSavvy
  • CVS Caremark
  • Editas
  • Express Scripts
  • Genentech
  • GlaxoSmithKline
  • Harvard Pilgrim Health Care
  • Health Care Service Corporation (HCSC)
  • HealthFirst
  • HealthPartners
  • Janssen
  • Kaiser Permanente
  • LEO Pharma
  • Mallinckrodt Pharmaceuticals
  • Merck & Co.
  • National Pharmaceutical Council
  • Novartis
  • Premera Blue Cross
  • Prime Therapeutics
  • Regeneron
  • Sanofi
  • United HealthCare